Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery

Molecular Pharmaceutics

Volumn 9, Issue 5, 2012, Pages 1262-1270

  Amoozgar, Zohreh ^a   Park, Joonyoung ^a   Lin, Qingnuo ^a   Yeo, Yoon ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

low molecular weight chitosans; nanoparticles; pH sensitive; stealth; tumor specific drug delivery

Indexed keywords

CHITOSAN; HYDROGEN PEROXIDE; LOW MOLECULAR WEIGHT CHITOSAN; NANOCOATING; PACLITAXEL; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CANCER CELL; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; DEACETYLATION; DRUG DELIVERY SYSTEM; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; MOLECULAR WEIGHT; NANOMEDICINE; OVARY CANCER; PH; PHAGOCYTE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TARGET CELL DESTRUCTION;

CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MICROSCOPY, CONFOCAL; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NANOPARTICLES; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID;

EID: 84860764149     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp2005615     Document Type: Article

References (31)

1. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K. L.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 2006, 66, 6732-6740
2. Mamot, C.; Drummond, D. C.; Noble, C. O.; Kallab, V.; Guo, Z. X.; Hong, K. L.; Kirpotin, D. B.; Park, J. W. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res. 2005, 65, 11631-11638
3. Bartlett, D. W.; Su, H.; Hildebrandt, I. J.; Weber, W. A.; Davis, M. E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 15549-15554
4. Moreno, D.; Zalba, S.; Navarro, I.; Tros de Ilarduya, C.; Garrido, M. J. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice Eur. J. Pharm. Biopharm. 2010, 74, 265-274
5. Carrstensen, H.; Müller, R. H.; Müller, B. W. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake Clin. Nutr. 1992, 11, 289-297
6. Otsuka, H.; Nagasaki, Y.; Kataoka, K. PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Delivery Rev. 2003, 55, 403-419
7. Huang, C.; Neoh, K. G.; Wang, L. A.; Kang, E. T.; Shuter, B. Magnetic nanoparticles for magnetic resonance imaging: modulation of macrophage uptake by controlled PEGylation of the surface coating J. Mater. Chem. 2010, 20, 8512-8520
8. Mishra, S.; Webster, P.; Davis, M. E. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles Eur. J. Cell Biol. 2004, 83, 97-111
9. Romberg, B.; Hennink, W.; Storm, G. Sheddable Coatings for Long-Circulating Nanoparticles Pharm. Res. 2008, 25, 55-71
10. Hong, R. L.; Huang, C. J.; Tseng, Y. L.; Pang, V. F.; Chen, S. T.; Liu, J. J.; Chang, F. H. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 1999, 5, 3645-3652
11. Hatakeyama, H.; Akita, H.; Harashima, H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma Adv. Drug Delivery Rev. 2011, 63, 152-160
12. Wolf, B. B.; Otto, A. M. A.; Brischwein, M. M.; Kraus, M. M.; Henning, T. T. Relevance of tumor microenvironment for progression, therapy and drug development Anti-Cancer Drugs 2004, 15, 7-14
13. Gerweck, L. E.; Seetharaman, K. Cellular pH Gradient in Tumor versus Normal Tissue: Potential Exploitation for the Treatment of Cancer Cancer Res. 1996, 56, 1194-1198
14. Tannock, I. F.; Rotin, D. Acid pH in tumors and its potential for therapeutic exploitation Cancer Res. 1989, 49, 4373-4384
15. Sawant, R. M.; Hurley, J. P.; Salmaso, S.; Kale, A.; Tolcheva, E.; Levchenko, T. S.; Torchilin, V. P. "SMART" drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers Bioconjugate Chem. 2006, 17, 943-949
16. Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J. Controlled Release 2011, 152, 2-12
17. Nie, Y.; Günther, M.; Gu, Z.; Wagner, E. Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding Biomaterials 2010, 32, 858-869
18. Sethuraman, V. A.; Bae, Y. H. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors J. Controlled Release 2007, 118, 216-224
19. Leane, M. M.; Nankervis, R.; Smith, A.; Illum, L. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms Int. J. Pharm. 2004, 271, 241-249
20. Xu, P.; Gullotti, E.; Tong, L.; Highley, C. B.; Errabelli, D. R.; Hasan, T.; Cheng, J.-X.; Kohane, D. S.; Yeo, Y. Intracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, Revisited Mol. Pharmaceutics 2009, 6, 190-201
21. Tian, F.; Liu, Y.; Hu, K. A.; Zhao, B. Y. Study of the depolymerization behavior of chitosan by hydrogen peroxide Carbohyd. Polym. 2004, 57, 31-37
22. Muzzarelli, R. A. A.; Peter, M. G.; Society, E. C. Chitin Handbook; Atec: Stafford, TX, 1997; pp 457-566.
23. He, P.; Davis, S. S.; Illum, L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres Int. J. Pharm. 1998, 166, 75-88
24. Lehr, C.-M.; Bouwstra, J. A.; Schacht, E. H.; Junginger, H. E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers Int. J. Pharm. 1992, 78, 43-48
25. Tahara, K.; Sakai, T.; Yamamoto, H.; Takeuchi, H.; Hirashima, N.; Kawashima, Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells Int. J. Pharm. 2009, 382, 198-204
26. Kim, B.-S.; Kim, C.-S.; Lee, K.-M. The intracellular uptake ability of chitosan-coated Poly(D,L-lactideco-glycolide) nanoparticles Arch. Pharm. Res. 2008, 31, 1050-1054
27. Zhang, L.; Gu, F. X.; Chan, J. M.; Wang, A. Z.; Langer, R. S.; Farokhzad, O. C. Nanoparticles in medicine: Therapeutic applications and developments Clin. Pharmacol. Ther. 2008, 83, 761-769
28. Owens, D. E.; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 2006, 307, 93-102
29. Zhou, J.; Romero, G.; Rojas, E.; Ma, L.; Moya, S.; Gao, C. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and folic acid binding to achieve selective cell targeting J. Colloid Interface Sci. 2010, 345, 241-247
30. Sarmento, B.; Mazzaglia, D.; Bonferoni, M. C.; Neto, A. P.; do Céu Monteiro, M.; Seabra, V. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system Carbohyd. Polym. 2011, 84, 919-925
31. Chung, Y.-I.; Kim, J. C.; Kim, Y. H.; Tae, G.; Lee, S.-Y.; Kim, K.; Kwon, I. C. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting J. Controlled Release 2010, 143, 374-382